𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Alpha-synuclein dysfunction in Lewy body diseases

✍ Scribed by George K. Tofaris; Maria Grazia Spillantini

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
116 KB
Volume
20
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis

alpha-Synuclein belongs to a small group of natively unfolded proteins that can transiently bind to lipid membranes and acquire a partial alpha-helical conformation. Its relevance to Parkinson's disease (PD) is based on mutations found in familial cases of the disease and its presence in filaments of Lewy bodies (LB) and Lewy neurites (LN) in sporadic cases where it is packed in a beta-sheet configuration. This structural plasticity of alpha-synuclein has raised the possibility that neurodegeneration may be a consequence of abnormal protein folding. The extent to which abnormal folding and aggregation of neuronal proteins is directly toxic to the cell, an inert biochemical marker of an underlying harmful metabolic defect, or a protective reaction remains to be seen. We review the function of alpha-synuclein and recent studies that have shed light on the mechanisms by which it aggregates.

📜 SIMILAR VOLUMES

Parkinson's disease, cortical dysfunctio
Parkinson's disease, cortical dysfunction, and alpha-synuclein
✍ John N. Caviness; Lih-Fen Lue; Thomas G. Beach; Joseph G. Hentz; Charles H. Adle 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB

## Abstract The ability to understand how Parkinson's disease neurodegeneration leads to cortical dysfunction will be critical for developing therapeutic advances in Parkinson's disease dementia. The overall purpose of this project was to study the small‐amplitude cortical myoclonus in Parkinson's

Alpha-synuclein mRNA expression in spora
Alpha-synuclein mRNA expression in sporadic Parkinson's disease
✍ Eng-King Tan; Van R. Chandran; Stephanie Fook-Chong; Hui Shen; Kenneth Yew; Mei- 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 1 views

## Abstract The expression of α‐synuclein gene can be influenced by the genomic load and/or epigenetic factors. By using quantitative real‐time polymerase chain reaction techniques, we demonstrated that the α‐synuclein gene mRNA expression in sporadic PD did not differ from healthy controls (median

Alpha-synuclein promoter haplotypes and
Alpha-synuclein promoter haplotypes and dementia in Parkinson's Disease
✍ E.V. De Marco; P. Tarantino; F.E. Rocca; G. Provenzano; D. Civitelli; V. De Luca 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 3 views

## Abstract Dementia is a common complication of Parkinson's disease (PD). It correlates significantly with the presence of cortical, limbic or nigral Lewy bodies, mainly constituted of alpha‐synuclein. Mutations of the alpha‐synuclein gene (SNCA) have been linked to rare familial forms of PD, whil

Levels of alpha-synuclein mRNA in sporad
Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients
✍ Ornit Chiba-Falek; Grisel J. Lopez; Robert L. Nussbaum 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 1 views

## Abstract Lewy bodies, the pathological hallmark of Parkinson's disease (PD), consist largely of α‐synuclein, a 14.5‐kDa presynaptic neuronal protein implicated in familial PD. An increased copy number and elevated expression of wild‐type α‐synuclein (__SNCA__) has been shown to cause early‐onset

Alpha-synuclein in colonic submucosa in
Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease
✍ Kathleen M. Shannon; Ali Keshavarzian; Ece Mutlu; Hemraj B. Dodiya; Delia Daian; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 479 KB

## Abstract The diagnosis of Parkinson's disease rests on motor signs of advanced central dopamine deficiency. There is an urgent need for disease biomarkers. Clinicopathological evidence suggests that α‐synuclein aggregation, the pathological signature of Parkinson's disease, can be detected in ga